Low Morning Cortisol in a Patient on Maintenance Prednisone
A low morning cortisol in a patient on maintenance prednisone indicates glucocorticoid-induced adrenal insufficiency (suppression of the HPA axis), which is expected and does not require intervention if the patient remains on prednisone for their underlying disease. The key question is whether you're trying to discontinue the prednisone or simply monitoring a patient who needs to stay on it.
Clinical Context Determines Management
The interpretation and management depend entirely on your clinical goal:
If the Patient Must Continue Prednisone for Their Underlying Disease
- Do not test for adrenal insufficiency while on supraphysiologic doses 1
- A low morning cortisol is expected and clinically irrelevant—the exogenous prednisone is providing adequate glucocorticoid coverage 2
- The patient should receive stress-dose coverage during major physiologic stress (sepsis, trauma, surgery) 1
- Continue current prednisone dose as dictated by the underlying disease
If You're Attempting to Discontinue Prednisone
This is where morning cortisol becomes clinically meaningful. First, ensure the underlying disease is controlled and glucocorticoids are no longer required 1. Then follow this algorithmic approach:
Stepwise Approach to Prednisone Discontinuation
Step 1: Taper to Physiologic Dose Range
- Gradually reduce prednisone to 4-6 mg daily (physiologic replacement range) 1
- Do not reduce below this range until HPA axis recovery is confirmed 1
- Monitor for glucocorticoid withdrawal syndrome (fatigue, myalgias, arthralgias)—if severe, temporarily increase dose and taper more slowly 1
Step 2: Assess HPA Axis Recovery
Once at physiologic doses (4-6 mg prednisone daily), you have two options 1:
Option A (Clinical Monitoring):
- Continue gradual taper while monitoring for adrenal insufficiency symptoms
- No biochemical testing required
Option B (Biochemical Confirmation - Preferred for Safety):
- Measure morning serum cortisol (8:00-9:00 AM) at least 24 hours after the last prednisone dose 1
Step 3: Interpret Morning Cortisol as a Continuum
The 2024 European Society of Endocrinology/Endocrine Society joint guideline provides clear thresholds 1:
Morning Cortisol >300 nmol/L (>10 μg/dL):
- HPA axis has recovered—glucocorticoids can be safely stopped 1
- Caveat: Patients near this threshold may still have suboptimal stress response; use clinical judgment and provide stress coverage if major stress occurs 1
Morning Cortisol 150-300 nmol/L (5-10 μg/dL):
- Continue physiologic prednisone dose (4-6 mg daily)
- Recheck morning cortisol in weeks to months 1
- Dynamic testing (ACTH stimulation) can be considered but is not routinely recommended 1
- Recent data shows 40-48% of patients in the 10-12 μg/dL range still fail stimulation testing 3, emphasizing the need for continued replacement
Morning Cortisol <150 nmol/L (<5 μg/dL):
- Very likely persistent adrenal insufficiency 1
- Continue physiologic prednisone dose (4-6 mg daily)
- Recheck morning cortisol in a few months 1
- Dynamic testing is unlikely to be useful 1
- Dose should provide adequate replacement while still stimulating HPA recovery (avoid over-replacement) 1
Critical Pitfalls to Avoid
Never test morning cortisol while on supraphysiologic prednisone doses—it will be suppressed and provides no useful information 1
Never reduce prednisone below physiologic replacement range (4-6 mg daily) without evidence of HPA recovery—this risks adrenal crisis 1
Always hold prednisone for 24 hours before measuring morning cortisol (except dexamethasone, which requires longer) 1
Recognize that biochemical suppression is common but clinically significant adrenal crisis is rare 1—the risk of meaningful adrenal insufficiency remains very low even with biochemical suppression
Provide stress-dose coverage during major physiologic stress even if morning cortisol suggests recovery, particularly for values near 300 nmol/L 1
Consider confounding factors: Morning cortisol can be falsely low with disrupted circadian rhythm (night shift, jet lag, insomnia) or falsely elevated with oral estrogens/pregnancy 1
When to Refer to Endocrinology
- No HPA axis recovery after one year on physiologic replacement dose 1
- History of adrenal crisis 1
- Difficulty tapering or complex cases
Key Nuance from FDA Labeling
The prednisone label emphasizes that HPA suppression duration is variable and depends on dose and duration of treatment 2. Recovery time is unpredictable, and patients remain vulnerable to stress during this recovery period 2. This underscores why the guideline recommends maintaining physiologic replacement until clear evidence of recovery.